Monday, October 23, 2023
International medical imaging IT and cybersecurity company, Sectra (STO: SECT B), has recently announced an expansion of its collaboration with Michigan Medicine, a prominent US health and academic center. The partnership now includes the integration of Sectra's digital pathology module within Michigan Medicine's enterprise imaging solution, enabling more efficient collaboration among pathologists and leading to enhanced cancer diagnostics in the region.
The adoption of digital pathology brings multiple benefits to healthcare facilities, pathologists, and patients. With Sectra's digital pathology solution, Michigan Medicine aims to streamline its operations, reduce costs, and improve the precision of diagnostic processes. Pathologists will now be able to combine their traditional microscopic examinations with digital tools, facilitating real-time collaboration and providing instant and remote access to digital images of tissue samples, eliminating the need for physical glass slides.
The unified platform for pathologists and radiologists will facilitate integrated diagnostics, particularly crucial in the realm of cancer care. This improved collaboration will increase efficiency, expedite the diagnosis process, and ensure patients receive accurate and timely treatment, ultimately enhancing their overall healthcare experience and outcomes. Sectra's innovative approach, merging radiology imaging with digital pathology, has had a transformative impact on healthcare institutions seeking comprehensive diagnostic capabilities.
Sectra's digital pathology solution is a component of their enterprise imaging solution, providing a unified approach to address all imaging requirements while optimizing operational costs. This scalable and modular solution, centered around a Vendor-Neutral Archive (VNA), offers healthcare providers the flexibility to expand across various specialties and healthcare enterprises seamlessly.